Trials for the new antisense oligonucleotide drug by Biogen.
Trials are taking place for the new antisense oligonucleotide drug by Biogen. Similar to Spinraza, but believed to have a better stability in the human body. This means larger dose can be administered through spinal tap at longer intervals compared to Spinraza. We believe they are aiming for every 180 days but yet to be…